Evopoint Biosciences is an innovative biopharmaceutical company with exceptional R&D and commercialization capabilities. Since its inception, Evopoint has been committed to improving human health by providing cutting-edge pharmaceutical solutions to advdress significant unmet medical needs globally.

By leveraging diverse discovery platforms in targeted therapy, next-generation ADCs, and targeted protein degradation (TPD), Evopoint has developed a robust pipeline targeting oncology, infectious diseases and metabolic diseases. Currently, we have 10 programs in clinical development and 10+ programs at discovery and preclinical development stages.